2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow EPs® 7630: new trials by email Literature Review of EPs® 7630 trials Research Report on EPs® 7630
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option EPs® 7630 - Hand, Foot, and Mouth Disease | Phase 2 / Phase 3 | Completed | Eskisehir Osmangazi University | 240 | 2019-06-01 | 2024-04-09 |
| Safety and Intake Effect of EPs® 7630 (an Extract of the Roots of Pelargonium Sidoides) EPs® 7630, Placebo - Common Cold | Phase 3 | Completed | Dr. Willmar Schwabe GmbH & Co. KG | 720 | 2014-03-01 | 2017-01-12 |
Common Cold (1) · Hand, Foot and Mouth Disease (1)
Dr. Willmar Schwabe GmbH & Co. KG (1) · Eskisehir Osmangazi University (1)
Turkey (Türkiye) (1) · United Kingdom (1)
Moutaz SM Jawad, M.B., B.Ch., FRCP (1)